Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process

Medical Physics

Volumn 38, Issue 12, 2011, Pages 6347-6350

  Carlson, David J ^a   Yenice, Kamil M ^b   Orton, Colin G ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYPOFRACTIONATED RADIOTHERAPIES; RADIORESISTANCE; TREATMENT PLANNING; TUMOR HYPOXIA;

EID: 82755181890     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3639137     Document Type: Note

References (22)

1. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck., Int. J. Radiat. Oncol., Biol., Phys. 38, 285-289 (1997). 10.1016/S0360-3016(97)00101-6 (Pubitemid 27318643)
2. P. Vaupel and M. Hockel, in Tumor Oxygenation, edited by, P. Vaupel, D. Kelleher, and, M. Gunderoth, (Gustav Fischer Verlag, Stuttgart, Germany, 1995), pp. 219-232.
3. J. M. Brown. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies., Mol. Med. Today 6, 157-162 (2000). 10.1016/S1357- 4310(00)01677-4 (Pubitemid 30171366)
4. E. K. Rofstad, K. Sundfor, H. Lyng, and C. G. Trope, Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis., Brit. J. Canc. 83, 354-359 (2000). 10.1054/bjoc.2000.1266 (Pubitemid 30453576)
5. J. M. Brown, M. Diehn, and B. W. Loo, Jr., Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer., Int. J. Radiat. Oncol., Biol., Phys. 78, 323-327 (2010). 10.1016/j.ijrobp.2009.07.1692
6. D. J. Carlson, P. J. Keall, B. W. Loo, Jr., Z. J. Chen, and J. M. Brown, Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia., Int. J. Radiat. Oncol., Biol., Phys. 79, 1188-1195 (2011). 10.1016/j.ijrobp.2010.10.007
7. S. M. Bentzen and V. Gregoire, Molecular imaging-based dose painting: A novel paradigm for radiation therapy prescription., Semin. Radiat. Oncol. 21, 101-110 (2011). 10.1016/j.semradonc.2010.10.001
8. Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography., Int. J. Radiat. Oncol., Biol., Phys. 70, 1219-1228 (2008). 10.1016/j.ijrobp.2007.06.073 (Pubitemid 351296122)
9. S. Benedict, K. Yenice, D. Followill, J. Galvin, W. Hinson, B. Kavanagh, P. Keall, M. Lovelock, S. Meeks, L. Papiez, T. Purdie, R. Sadagopan, M. Schell, B. Salter, D. Schlesinger, A. Shiu, T. Solberg, D. Song, V. Stieber, R. Timmerman, W. Tome, D. Verellen, L. Wang, and F. Yin, Stereotactic body radiation therapy: The report of AAPM Task Group No. 101., Med. Phys. 37, 4078-4101 (2010). 10.1118/1.3438081
10. I. S. Grills, V. S. Mangona, R. Welsh, G. Chmielewski, E. McInerney, S. Martin, J. Wloch, H. Ye, and L. L. Kestin. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer., J. Clin. Oncol. 28, 928-935 (2010). 10.1200/JCO.2009.25.0928
11. R. D. Timmerman, C. S. Bizekis, H. I. Pass, Y. Fong, D. E. Dupuy, L. A. Dawson, and D. Lu. Local surgical, ablative, and radiation treatment of metastases., Ca-Cancer J. Clin. 59, 145-170 (2009). 10.3322/caac.20013
12. R. Ruggieri, S. Naccarato, and A. E. Nahum. Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia., Acta Oncol. 49, 1304-1314 (2010). 10.3109/0284186X.2010.486796
13. A. R. Padhani, K. A. Krohn, J. S. Lewis, and M. Alber, Imaging oxygenation of human tumours., Eur. Radiol. 17, 861-872 (2007). 10.1007/s00330-006-0431-y (Pubitemid 46772763)
14. S. A. Nehmeh, Reproducibility of intratumor distribution of 18F-fluoromisonidazole in head and neck cancer., Int. J. Radiat. Oncol., Biol., Phys. 70, 235-242 (2008). 10.1016/j.ijrobp.2007.08.036 (Pubitemid 350251048)
15. C. C. Ling, Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality., Int. J. Radiat. Oncol., Biol., Phys. 47, 551-560 (2000). 10.1016/S0360-3016(00)00467-3 (Pubitemid 30317470)
16. I. Toma-Dau, J. Uhrdin, A. Dau, and A. Brahme, Therapy optimization based on non-linear uptake of PET tracers versus linear dose painting., IFMBE Proc. 25, 221-224 (2009). 10.1007/978-3-642-03474-9-63
17. Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography., Int. J. Radiat. Oncol., Biol., Phys. 70, 1219-1228 (2008). 10.1016/j.ijrobp.2007.06.073 (Pubitemid 351296122)
18. D. Thorwarth, S. M. Eschmann, F. Paulsen, and M. Alber, Hypoxia dose painting by numbers: A planning study., Int. J. Radiat. Oncol., Biol., Phys. 68, 291-300 (2007). 10.1016/j.ijrobp.2006.12.037 (Pubitemid 46589864)
19. J. F. Fowler, The linear-quadratic formula and progress in fractionated radiotherapy., Brit. J. Radiol. 62, 679-694 (1989). 10.1259/0007-1285-62-740-679 (Pubitemid 19194494)
20. J. P. Kirkpatrick, J. J. Meyer, and L. B. Marks, The Linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery., Sem. Radiat. Oncol. 18, 240-243 (2008). 10.1016/j.semradonc.2008.04.005
21. M. Kocher, Adjuvant whole brain radiotherapy vs observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study., Int. J. Radiat. Oncol., Biol., Phys. 75, S5, Abstract (2009).
22. J. Overgard and M. R. Horsman, Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers., Sem. Radiat. Oncol. 6, 10-21 (1996). 10.1016/S1053-4296(96)80032-4 (Pubitemid 26029371)